scholarly journals Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer

2017 ◽  
Vol 37 (8) ◽  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Small Cell ◽  
Second Line ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy

2021 ◽  
pp. canres.CAN-21-2964-E.2021
Author(s):  
Alvaro Quintanal-Villalonga ◽  
Hirokazu Taniguchi ◽  
Yuan Hao ◽  
Andrew Chow ◽  
Yingqian A Zhan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

2003 ◽  
Vol 35 (4) ◽  
pp. 294-298
Author(s):  
Yoon Jae Kim ◽  
Joo Hyuk Sohn ◽  
Chul Kim ◽  
Yong Tai Kim ◽  
Hai Jin Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Cisplatin and Etoposide as Second-Line Chemotherapy in Patients with Small Cell Lung Cancer

1988 ◽  
Vol 6 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Franco Figoli ◽  
Andrea Veronesi ◽  
Andrea Ardizzoni ◽  
Luciano Canobbio ◽  
Gioia Bruschi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document